login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
MURAL ONCOLOGY PLC (MURA) Stock News
USA
- NASDAQ:MURA -
IE000LK2BOB4
-
Common Stock
2.09
USD
-0.01 (-0.48%)
Last: 10/31/2025, 8:01:55 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MURA Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Mural Oncology plc
- Mentions:
XOMA
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty
9 days ago - By: Mural Oncology plc
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty
a month ago - By: Halper Sadeh LLC
- Mentions:
PHLT
ARIS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders
2 months ago - By: Stocktwits
- Mentions:
XOMA
Mural Oncology To Be Acquired By Xoma Royalty
3 months ago - By: The Motley Fool
Mural Oncology (MURA) Q2 Loss Widens 49%
6 months ago - By: Mural Oncology plc
FORM 8.1(a) & (b) - Mural Oncology plc
a month ago - By: Mural Oncology plc
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
a month ago - By: Mural Oncology plc
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
a month ago - By: Halper Sadeh LLC
- Mentions:
ARIS
MTSR
GTLS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders
7 months ago - By: Stocktwits
Mural Oncology's Retail Buzz Explodes After Micro-Cap Biotech Mulls Strategic Alternatives
7 months ago - By: Benzinga
- Mentions:
CRMD
CNSP
DATS
TNON
...
Nasdaq Gains 50 Points; US New Home Sales Rise In February
2 months ago - By: Halper Sadeh LLC
- Mentions:
NWE
GES
TZUP
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders
2 months ago - By: Halper Sadeh LLC
MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to Shareholders
7 months ago - By: Benzinga
- Mentions:
CNSP
CNM
DATS
MULN
...
US Stocks Mixed; Core & Main Posts Downbeat Earnings
2 months ago - By: Mural Oncology plc
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
3 months ago - By: Mural Oncology plc
Mural Oncology Announces Second Quarter Financial Results and Provides Business Update
3 months ago - By: Mural Oncology plc
Mural Oncology Announces Second Quarter Financial Results and Provides Business Update
6 months ago - By: Mural Oncology plc
Mural Oncology Announces Number of Relevant Securities in Issue
7 months ago - By: Mural Oncology, Inc.
Mural Oncology Announces Plans to Explore Strategic Alternatives
Please enable JavaScript to continue using this application.